CIK 0000786947
ACUR ACURA PHARMACEUTICALS, INC
Insider trading from SEC Form 4. Last filing Jan 15, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Signals
Open-market buys and sells at ACURA PHARMACEUTICALS, INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 18 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | William G Skelly director | MOption exercise Common Stock | +50,000 | - | - | 675,989 | Jan 15, 2026 |
| Jan 2, 2026 | Immanuel Thangaraj director | MOption exercise Common Stock | +50,000 | - | - | 547,647 | Jan 15, 2026 |
| Jan 2, 2026 | George K Ross director | MOption exercise Common Stock | +50,000 | - | - | 595,903 | Jan 15, 2026 |
| Jan 2, 2026 | George K Ross director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 15, 2026 |
| Jan 2, 2026 | William G Skelly director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 15, 2026 |
| Jan 2, 2026 | George K Ross director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 15, 2026 |
| Jan 2, 2026 | William G Skelly director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 15, 2026 |
| Jan 2, 2026 | Immanuel Thangaraj director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 15, 2026 |
| Jan 2, 2026 | Immanuel Thangaraj director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 15, 2026 |
| Jan 2, 2025 | Immanuel Thangaraj director | MOption exercise Common Stock | +50,000 | - | - | 497,647 | Feb 4, 2025 |
| Jan 2, 2025 | Immanuel Thangaraj director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Feb 4, 2025 |
| Jan 2, 2025 | Immanuel Thangaraj director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Feb 4, 2025 |
| Jan 2, 2025 | William G Skelly director | MOption exercise Common Stock | +50,000 | - | - | 625,989 | Jan 24, 2025 |
| Jan 2, 2025 | George K Ross director | MOption exercise Common Stock | +50,000 | - | - | 545,503 | Jan 24, 2025 |
| Jan 2, 2025 | William G Skelly director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 24, 2025 |
| Jan 2, 2025 | George K Ross director | MOption exercise Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 0 | Jan 24, 2025 |
| Jan 2, 2025 | William G Skelly director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 24, 2025 |
| Jan 2, 2025 | George K Ross director | AGrant or award Restricted Stock Units (2021 Plan)derivative | -50,000 | - | - | 50,000 | Jan 24, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- George K Rossdirector
- William G Skellydirector
- Immanuel Thangarajdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.